E3 PreliminaryPreliminaryPEM unclearCross-SectionalPeer-reviewedMachine draft
Chronic fatigue syndrome is accompanied by an IgM-related immune response directed against neopitopes formed by oxidative or nitrosative damage to lipids and proteins.
Maes, Michael, Mihaylova, Ivana, Leunis, Jean-Claude · Neuro endocrinology letters · 2006
Quick Summary
This study found that people with ME/CFS have higher levels of immune antibodies (IgM) attacking damaged fats and proteins in their bodies. These antibodies target substances created when cells are damaged by oxidative stress—a harmful process where the body's natural defenses become imbalanced. The more severe someone's ME/CFS symptoms were, the higher their antibody levels tended to be.
Why It Matters
This research provides potential biological evidence that oxidative and nitrosative stress—harmful chemical processes in cells—may play a role in ME/CFS pathophysiology. Finding measurable immune markers could eventually help explain ME/CFS mechanisms and potentially support development of biomarkers for diagnosis or monitoring disease progression.
Observed Findings
- IgM antibody levels against multiple oxidatively and nitrosatively modified lipids and amino acids were significantly elevated in CFS patients versus controls.
- Partial CFS patients showed intermediate antibody levels between full CFS and healthy controls.
- Significant positive correlations existed between IgM levels and disease severity measured by FibroFatigue scale.
- CFS patients showed elevated IgM responses to fatty acids (oleic, palmitic, myristic), lipid peroxidation byproducts (MDA, azelaic acid), and multiple nitro-modified amino acids.
- Symptoms including aches, pain, muscular tension, and fatigue correlated positively with antibody levels.
Inferred Conclusions
- ME/CFS is characterized by an IgM-mediated immune response against neoepitopes generated by oxidative and nitrosative damage to cell membranes and proteins.
- Oxidative and nitrosative stress appears to be a significant pathophysiological feature of ME/CFS, with immune markers correlating to symptom severity.
- The immune system in ME/CFS patients mounts responses against molecular damage products normally not recognized as immunogenic, suggesting abnormal oxidative stress or impaired tolerance mechanisms.
Remaining Questions
- Does oxidative/nitrosative stress cause ME/CFS or result from the disease process?
What This Study Does Not Prove
This study does not establish whether oxidative damage is a cause or consequence of ME/CFS, nor does it prove these immune responses are pathogenic rather than a secondary reaction. The small cross-sectional design cannot demonstrate causality, and findings require replication in larger, independent cohorts before clinical application is warranted.
Tags
Symptom:PainFatigue
Biomarker:AutoantibodiesBlood Biomarker
Method Flag:Weak Case DefinitionSmall SampleExploratory Only
Metadata
- PMID
- 17159817
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →